Advertisement

Psychiatric Differential Diagnosis of Psychosis

  • Oliver Freudenreich
Chapter
Part of the Current Clinical Psychiatry book series (CCPSY)

Abstract

Primary psychotic disorders include a wide variety of psychiatric disorders, including but not limited to schizophrenia spectrum disorders. In this chapter, I describe the clinical characteristics of psychiatric disorders where psychosis is an obligatory part of the symptom picture (i.e., schizophrenia spectrum disorders) or where psychosis is merely an ancillary but not core feature (i.e., psychotic mood disorder). Included in this chapter is catatonia because its recognition is important for treatment.

Keywords

Schizophrenia spectrum disorders Differential diagnosis Schizoaffective disorder Schizotypal disorder Schizoid personality disorder Delusional disorder Atypical psychosis Cycloid psychoses Acute and transient psychotic disorders (ATPD) Psychotic mood disorders Psychotic depression Psychotic mania Folie a deux Catatonia Obsessive-compulsive disorder Autism 

References

  1. 1.
    Wikiquote. William S. Burroughs. Available from: https://en.wikiquote.org/wiki/William_S._Burroughs. Accessed on 7/1/2019.
  2. 2.
    Gaebel W. Status of psychotic disorders in ICD-11. Schizophr Bull. 2012;38:895–8.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Bleuler E. Dementia praecox or the group of schizophrenias. New York: International Universities Press; 1911/1950.Google Scholar
  4. 4.
    Braff DL, Ryan J, Rissling AJ, Carpenter WT. Lack of use in the literature from the last 20 years supports dropping traditional schizophrenia subtypes from DSM-5 and ICD-11. Schizophr Bull. 2013;39:751–3.CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    McLean RT, Wilson P, St Clair D, Mustard CJ, Wei J. Differential antibody responses to gliadin-derived indigestible peptides in patients with schizophrenia. Transl Psychiatry. 2017;7:e1121.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Tomasik J, Lago SG, Vazquez-Bourgon J, Papiol S, Suarez-Pinilla P, Crespo-Facorro B, et al. Association of insulin resistance with schizophrenia polygenic risk score and response to antipsychotic treatment. JAMA Psychiatry. 2019; (in press).Google Scholar
  7. 7.
    Bowen EFW, Burgess JL, Granger R, Kleinman JE, Rhodes CH. DLPFC transcriptome defines two molecular subtypes of schizophrenia. Transl Psychiatry. 2019;9:147.CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Peterson DL, Webb CA, Keeley JW, Gaebel W, Zielasek J, Rebello TJ, et al. The reliability and clinical utility of ICD-11 schizoaffective disorder: a field trial. Schizophr Res. 2019;208:235–41.CrossRefGoogle Scholar
  9. 9.
    American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-5. 5th ed. Arlington: American Psychiatric Association; 2013.CrossRefGoogle Scholar
  10. 10.
    Santelmann H, Franklin J, Busshoff J, Baethge C. Interrater reliability of schizoaffective disorder compared with schizophrenia, bipolar disorder, and unipolar depression – a systematic review and meta-analysis. Schizophr Res. 2016;176:357–63.CrossRefGoogle Scholar
  11. 11.
    Heckers S. Is schizoaffective disorder a useful diagnosis? Curr Psychiatry Rep. 2009;11:332–7.CrossRefGoogle Scholar
  12. 12.
    Malaspina D, Owen MJ, Heckers S, Tandon R, Bustillo J, Schultz S, et al. Schizoaffective disorder in the DSM-5. Schizophr Res. 2013;150:21–5.CrossRefGoogle Scholar
  13. 13.
    Legesse B, Freudenreich O, Murray E, Price B. A case report of confusional psychosis with abrupt onset and rapid resolution of symptoms. Psychosomatics. 2011;52:468–71.CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Marneros A. Beyond the Kraepelinian dichotomy: acute and transient psychotic disorders and the necessity for clinical differentiation. Br J Psychiatry. 2006;189:1–2.CrossRefGoogle Scholar
  15. 15.
    Castagnini AC, Fusar-Poli P. Diagnostic validity of ICD-10 acute and transient psychotic disorders and DSM-5 brief psychotic disorder. Eur Psychiatry. 2017;45:104–13.CrossRefGoogle Scholar
  16. 16.
    Teichmann G. The influence of Karl Kleist on the nosology of Karl Leonhard. Psychopathology. 1990;23:267–76.CrossRefGoogle Scholar
  17. 17.
    Salvatore P, Bhuvaneswar C, Ebert D, Maggini C, Baldessarini RJ. Cycloid psychoses revisited: case reports, literature review, and commentary. Harv Rev Psychiatry. 2008;16:167–80.CrossRefGoogle Scholar
  18. 18.
    Naz B, Bromet EJ, Mojtabai R. Distinguishing between first-admission schizophreniform disorder and schizophrenia. Schizophr Res. 2003;62:51–8.CrossRefGoogle Scholar
  19. 19.
    Malhotra S, Varma VK, Misra AK, Das S, Wig NN, Santosh PJ. Onset of acute psychotic states in India: a study of sociodemographic, seasonal and biological factors. Acta Psychiatr Scand. 1998;97:125–31.CrossRefGoogle Scholar
  20. 20.
    Gajwani AK, Abdi S, Adwani GB. The Othello syndrome. Can J Psychiatr. 1983;28:157–8.CrossRefGoogle Scholar
  21. 21.
    Jordan HW, Lockert EW, Johnson-Warren M, Cabell C, Cooke T, Greer W, et al. Erotomania revisited: thirty-four years later. J Natl Med Assoc. 2006;98:787–93.PubMedPubMedCentralGoogle Scholar
  22. 22.
    Campbell EH, Elston DM, Hawthorne JD, Beckert DR. Diagnosis and management of delusional parasitosis. J Am Acad Dermatol. 2019;80:1428–34.CrossRefGoogle Scholar
  23. 23.
    Skimming KA, Miller CWT. Transdiagnostic approach to olfactory reference syndrome: neurobiological considerations. Harv Rev Psychiatry. 2019;27:193–200.CrossRefGoogle Scholar
  24. 24.
    Munro A, Chmara J. Monosymptomatic hypochondriacal psychosis: a diagnostic checklist based on 50 cases of the disorder. Can J Psychiatr. 1982;27:374–6.CrossRefGoogle Scholar
  25. 25.
    Freudenreich O, Kontos N, Tranulis C, Cather C. Morgellons disease, or antipsychotic-responsive delusional parasitosis, in an HIV patient: beliefs in the age of the internet. Psychosomatics. 2010;51:453–7.CrossRefGoogle Scholar
  26. 26.
    Opler LA, Klahr DM, Ramirez PM. Pharmacologic treatment of delusions. Psychiatr Clin North Am. 1995;18:379–91.CrossRefGoogle Scholar
  27. 27.
    Bartels J, Ryan CJ. How should physicians sse their authority to name a stigmatizing diagnosis and respond to a patient’s experience? AMA J Ethics. 2018;20:E1119–25.CrossRefGoogle Scholar
  28. 28.
    Murphy M, Kontos N, Freudenreich O. Electronic support groups: an open line of communication in contested illness. Psychosomatics. 2016;57:547–55.CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    Delgado MG, Bogousslavsky J. De Clerambault syndrome, Othello syndrome, folie a deux and variants. Front Neurol Neurosci. 2018;42:44–50.CrossRefGoogle Scholar
  30. 30.
    Logan TK, Walker R. Stalking: a multidimensional framework for assessment and safety planning. Trauma Violence Abuse. 2017;18:200–22.CrossRefGoogle Scholar
  31. 31.
    Gara MA, Minsky S, Silverstein SM, Miskimen T, Strakowski SM. A naturalistic study of racial disparities in diagnoses at an outpatient behavioral health clinic. Psychiatr Serv. 2019;70:130–4.CrossRefGoogle Scholar
  32. 32.
    Mitchell PB, Wilhelm K, Parker G, Austin MP, Rutgers P, Malhi GS. The clinical features of bipolar depression: a comparison with matched major depressive disorder patients. J Clin Psychiatry. 2001;62:212–6.CrossRefGoogle Scholar
  33. 33.
    Gournellis R, Tournikioti K, Touloumi G, Thomadakis C, Michalopoulou PG, Christodoulou C, et al. Psychotic (delusional) depression and suicidal attempts: a systematic review and meta-analysis. Acta Psychiatr Scand. 2018;137:18–29.CrossRefGoogle Scholar
  34. 34.
    Dieguez S. Cotard syndrome. Front Neurol Neurosci. 2018;42:23–34.CrossRefGoogle Scholar
  35. 35.
    Lykouras E, Christodoulou GN, Malliaras D. Type and content of delusions in unipolar psychotic depression. J Affect Disord. 1985;9:249–52.CrossRefGoogle Scholar
  36. 36.
    Nelson EB. Psychotic depression--beyond the antidepressant/antipsychotic combination. Curr Psychiatry Rep. 2012;14:619–23.CrossRefGoogle Scholar
  37. 37.
    Farahani A, Correll CU. Are antipsychotics or antidepressants needed for psychotic depression? A systematic review and meta-analysis of trials comparing antidepressant or antipsychotic monotherapy with combination treatment. J Clin Psychiatry. 2012;73:486–96.CrossRefPubMedPubMedCentralGoogle Scholar
  38. 38.
    Ghaemi SN, Wingo AP, Filkowski MA, Baldessarini RJ. Long-term antidepressant treatment in bipolar disorder: meta-analyses of benefits and risks. Acta Psychiatr Scand. 2008;118:347–56.CrossRefPubMedPubMedCentralGoogle Scholar
  39. 39.
    McGirr A, Vohringer PA, Ghaemi SN, Lam RW, Yatham LN. Safety and efficacy of adjunctive second-generation antidepressant therapy with a mood stabiliser or an atypical antipsychotic in acute bipolar depression: a systematic review and meta-analysis of randomised placebo-controlled trials. Lancet Psychiatry. 2016;3:1138–46.CrossRefPubMedPubMedCentralGoogle Scholar
  40. 40.
    Pacchiarotti I, Bond DJ, Baldessarini RJ, Nolen WA, Grunze H, Licht RW, et al. The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders. Am J Psychiatry. 2013;170:1249–62.CrossRefPubMedPubMedCentralGoogle Scholar
  41. 41.
    Avery LM, Drayton SJ. Bipolar depression: managing patients with second generation antipsychotics. Int J Psychiatry Med. 2016;51:145–59.CrossRefGoogle Scholar
  42. 42.
    Azorin JM, Akiskal H, Akiskal K, Hantouche E, Chatenet-Duchene L, Gury C, et al. Is psychosis in DSM-IV mania due to severity? The relevance of selected demographic and comorbid social-phobic features. Acta Psychiatr Scand. 2007;115:29–34.CrossRefGoogle Scholar
  43. 43.
    Peralta V, Cuesta MJ. Diagnostic significance of Schneider’s first-rank symptoms in schizophrenia. Comparative study between schizophrenic and non-schizophrenic psychotic disorders. Br J Psychiatry. 1999;174:243–8.CrossRefPubMedPubMedCentralGoogle Scholar
  44. 44.
    Yatham LN, Kennedy SH, Parikh SV, Schaffer A, Bond DJ, Frey BN, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder. Bipolar Disord. 2018;20:97–170.CrossRefPubMedPubMedCentralGoogle Scholar
  45. 45.
    Shimizu M, Kubota Y, Toichi M, Baba H. Folie a deux and shared psychotic disorder. Curr Psychiatry Rep. 2007;9:200–5.CrossRefGoogle Scholar
  46. 46.
    Taylor MA, Fink M. Catatonia in psychiatric classification: a home of its own. Am J Psychiatry. 2003;160:1233–41.CrossRefGoogle Scholar
  47. 47.
    Tandon R, Heckers S, Bustillo J, Barch DM, Gaebel W, Gur RE, et al. Catatonia in DSM-5. Schizophr Res. 2013;150:26–30.CrossRefGoogle Scholar
  48. 48.
    Ungvari GS, Caroff SN, Gerevich J. The catatonia conundrum: evidence of psychomotor phenomena as a symptom dimension in psychotic disorders. Schizophr Bull. 2010;36:231–8.CrossRefGoogle Scholar
  49. 49.
    Madigand J, Lebain P, Callery G, Dollfus S. Catatonic syndrome: from detection to therapy. Encéphale. 2016;42:340–5.CrossRefGoogle Scholar
  50. 50.
    Rosell DR, Futterman SE, McMaster A, Siever LJ. Schizotypal personality disorder: a current review. Curr Psychiatry Rep. 2014;16:452.CrossRefPubMedPubMedCentralGoogle Scholar
  51. 51.
    Bedwell JS, Donnelly RS. Schizotypal personality disorder or prodromal symptoms of schizophrenia? Schizophr Res. 2005;80:263–9.CrossRefGoogle Scholar
  52. 52.
    Zink M. Comorbid obsessive-compulsive symptoms in schizophrenia: insight into pathomechanisms facilitates treatment. Adv Med. 2014;2014:317980.CrossRefPubMedPubMedCentralGoogle Scholar
  53. 53.
    Rodriguez CI, Corcoran C, Simpson HB. Diagnosis and treatment of a patient with both psychotic and obsessive-compulsive symptoms. Am J Psychiatry. 2010;167:754–61.CrossRefGoogle Scholar
  54. 54.
    Scotti-Muzzi E, Saide OL. Schizo-obsessive spectrum disorders: an update. CNS Spectr. 2017;22:258–72.CrossRefGoogle Scholar
  55. 55.
    Leung JG, Palmer BA. Psychosis or obsessions? Clozapine associated with worsening obsessive-compulsive symptoms. Case Rep Psychiatry. 2016;2016:2180748.PubMedPubMedCentralGoogle Scholar
  56. 56.
    Canitano R, Pallagrosi M. Autism spectrum disorders and schizophrenia spectrum disorders: excitation/inhibition imbalance and developmental trajectories. Front Psych. 2017;8:69.CrossRefGoogle Scholar
  57. 57.
    Rapoport J, Chavez A, Greenstein D, Addington A, Gogtay N. Autism spectrum disorders and childhood-onset schizophrenia: clinical and biological contributions to a relation revisited. J Am Acad Child Adolesc Psychiatry. 2009;48:10–8.CrossRefPubMedPubMedCentralGoogle Scholar
  58. 58.
    De Crescenzo F, Postorino V, Siracusano M, Riccioni A, Armando M, Curatolo P, et al. Autistic symptoms in schizophrenia spectrum disorders: a systematic review and meta-analysis. Front Psych. 2019;10:78.CrossRefGoogle Scholar
  59. 59.
    Driver DI, Gogtay N, Rapoport JL. Childhood onset schizophrenia and early onset schizophrenia spectrum disorders. Child Adolesc Psychiatr Clin N Am. 2013;22:539–55.CrossRefPubMedPubMedCentralGoogle Scholar
  60. 60.
    Cross-Disorder Group of the Psychiatric Genomics C, Lee SH, Ripke S, Neale BM, Faraone SV, Purcell SM, et al. Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat Genet. 2013;45:984–94.CrossRefGoogle Scholar
  61. 61.
    Buckley PF, Miller BJ, Lehrer DS, Castle DJ. Psychiatric comorbidities and schizophrenia. Schizophr Bull. 2009;35:383–402.CrossRefGoogle Scholar
  62. 62.
    Morrison KE, Pinkham AE, Penn DL, Kelsven S, Ludwig K, Sasson NJ. Distinct profiles of social skill in adults with autism spectrum disorder and schizophrenia. Autism Res. 2017;10:878–87.CrossRefPubMedPubMedCentralGoogle Scholar

Additional Resources

    Books

    1. McKenna P. Delusions: understanding the un-understandable. Cambridge: Cambridge University Press; 2017. – Our current understanding of the un-understandable (a criterion for delusions, “Unverstehbarkeit,” according to Karl Jaspers). This book includes a section on delusional disorder.Google Scholar

    Article

    1. Gerevich J, Ungvari GS. The description of the litigious querulant: Heinrich von Kleist’s Novella Michael Kohlhaas. Psychopathology. 2015;48:79–83. – If you find the time, get the short book by the German romantic writer (available in English) and read his classic case study about how an injustice becomes an all-consuming quest for justice, resulting in catastrophe. You may recognize in Kohlhaas patients in your treatment system whose life mission is litigation to rectify a wrong. While the term querulant paranoia is sometimes employed, some patients may be better described by having overvalued ideas.Google Scholar
    2. Freudenreich O, Kontos N, Tranulis C, Cather C. Morgellons disease, or antipsychotic-responsive delusional parasitosis, in an HIV patient: beliefs in the age of the Internet. Psychosomatics. 2010;51:453–7. – A discussion of one of the contested diseases and the power struggle between patients and physicians about who has the authority to make diagnoses.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  • Oliver Freudenreich
    • 1
  1. 1.Department of PsychiatryMassachusetts General HospitalBostonUSA

Personalised recommendations